Pharmafile Logo

First Edition Translations Ltd

Founded in 1981, First Edition Translations Ltd is one of the UK’s oldest established translation agencies and a founder member of the Institute of Translation and Interpreting. Our team of professional medical translators are fluent in over 30 languages, ensuring your documents and materials are accurately translated.

First Edition offers diverse medical translation services that cover a broad range of materials, including:
Regulatory and legal documents
SPCs, PILs, labelling, treatment manuals
Clinical trials, assessments
Research studies, papers and abstracts
Information, manufacturing and marketing materials, IFUs
Specialist published materials, including catalogues, industry magazines and newsletters
Websites, apps and software

We value accuracy, reliability and outstanding quality, making us a trusted partner for all your medical and pharmaceutical translations. Adhering to the ISO 17100 standard, we can provide certification for our work upon request. If you’d like further advice, our friendly and multilingual project management team is always happy to help.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Atlas Translations Ltd

With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Company Details

6 Wellington Court, Wellington Street, Cambridge, CB1 1HZ, United Kingdom
+44 (0)1223 356 733

 Latest Content from PMHub 

Video: Global Biosimilars Market

Research director of Therapy Watch, Laurent Chanroux, discusses the growth opportunities for biosimilars and the importance of adaptable market tracking for pre and post product launch

Case study: Understanding Patient Willingness to Pay in Emerging Markets

Our client wanted to identify the optimum selling price for their chronic disease treatment in emerging markets, based on patient’s willingness to pay for the product out of pocket.Find out...

From promise to practice: immuno-oncology in action Part 3 – Emerging Markets

Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.

Lucid reach the shortlist for Communiqué 2016 in SIX categories

Lucid Group are celebrating the news that for the first time they have been shortlisted in six different categories at this year’s Communiqué awards.  The categories are:Excellence in Communications of...

The difference between market intelligence and design intelligence

Blue Latitude Health's Elisa del Galdo explains how market and customer research differ, and in which situations you would use one over the other.

The Missing Ingredient in Online Healthcare: Trust

By Brad Davidson, PhD, SVP Strategic Planning, Aptus Health

Lucid Co-founder and COO discusses the changing landscape of healthcare communications

In May’s issue, Jan Steele (Lucid co-founder and COO) talks to PME about the importance of demonstrating value with medical education via validated improvements in patient outcomes. Jan explains that...

Lost for words? Try picturing this… by Mark Spain and Sharon Ombler-Spain

The Two Visual Thinkers' blog about the benefits of recording information visually to engage and educate a variety of audiences.

New talent blooms at Lucid Group

Spring has most definitely sprung at Lucid Group as they welcome three new employees to their team. Laura Cunliffe joins as a Senior Account Manager at Leading Edge and will...